ALM (Evotec/MedImmune)

N/A

Report date: 2025/03/14 16:30:38
NME

Base Information

Drug NameALM (Evotec/MedImmune)
Drug Alias NameALM
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRegenerating islet-derived protein 3-alpha agonists
TargetsRegenerating islet-derived protein 3-alpha
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEvotec SE
China Registration ClassN/A

Develop Information

Active CompaniesMedimmune LlcEvotec SE
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A